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To evaluate the effects of supervised exercise training (SET) on cardiometabolic risk, cardiorespiratory
fitness and oxidative stress status in 2 diabetes mellitus (T2DM), twenty male subjects with T2DM were
randomly assigned to an intervention group, which performed SET in a hospital-based setting, and to a
control group. SET consisted of a 12-month supervised aerobic, resistance and flexibility training. A
reference group of ten healthy male subjects was also recruited for baseline evaluation only. Participants
underwent medical examination, biochemical analyses and cardiopulmonary exercise testing.
Oxidative stress markers (1-palmitoyl-2-[5-oxovaleroyl]-sn-glycero-3-phosphorylcholine [POVPC];
1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcholine [PGPC]) were measured in plasma and in
peripheral bloodmononuclear cells. All investigations were carried out at baseline and after 12months. SET
yielded a significant modification (p, 0.05) in the following parameters: V’O2max (114.4%), gas exchange
threshold (123.4%), waist circumference (21.4%), total cholesterol (214.6%), LDL cholesterol (220.2%),
fasting insulinemia (248.5%), HOMA-IR (252.5%), plasma POVPC (227.9%) and PGPC (231.6%). After
12months, the control group presented a V’O2max and a gas exchange threshold significantly lower than the
intervention group. Plasma POVC and PGPC were significantly different from healthy subjects before the
intervention, but not after. In conclusion, SET was effective in improving cardiorespiratory fitness,
cardiometabolic risk and oxidative stress status in T2DM.
P
hysiological levels of reactive oxygen species (ROS) are important to maintain various cell functions,
although an overload of ROS that exceeds the capacity of the antioxidant system can induce oxidative
stress1. Oxidative stress plays a key role in both initiation and complications of type 2 diabetes mellitus
(T2DM)2. The phospholipid 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (PAPC) is a major
component of cell membranes and lipoproteins. Oxidation products of PAPC (lumped together under the
abbreviation oxPAPC) are found in cells during inflammation, in membranes of apoptotic cells, as well as in
oxidized low density lipoproteins and are considered sensitive markers of systemic oxidative stress3. oxPAPC can
be isolated directly from plasma or from peripheral blood mononuclear cells (PBMC). Plasma oxPAPC comes
from lipoproteins and fragments of apoptotic cells, while PBMC oxPAPC originates from incorporation into cell
membranes and is used as in vivo surrogates of endothelial cells3. Furthermore, it has been demonstrated that
ROS generation frommononuclear cells in response to hyperglycemiamay contribute to a proinflammatory state
that induces insulin resistance, even in the absence of increased abdominal adiposity4.
Cardiorespiratory fitness is the ability to transfer oxygen from ambient air to skeletal muscle mitochondria
during sustained exercise with largemuscle groups, whose criterionmeasure is themaximal oxygen consumption
( _VO2max), a concept that implies a precise interplay between pulmonary, cardiovascular and neuromuscular
apparatuses5. A low cardiorespiratory fitness represents a greater risk factor than obesity for the development of
type 2 diabetes mellitus (T2DM)6 and subjects with T2DM, in the absence of complications, have a decreased
exercise performance compared to healthy subjects7. In addition, an exercise intervention per se can improve
blood glucose control and cardiovascular risk in T2DM8,9, especially if a combination of aerobic and resistance
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training is performed regularly and for a long period of time10. To
mechanistically explain these observations, it has been hypothesized
that endurance training enhances antioxidant capacity11–13 and
reduces systemic low-grade inflammation14. This is particularly evid-
ent in mononuclear cells of insulin-resistant obese subjects15 as well
in subjects with T2DM14. As a consequence, beta-cell function, insu-
lin sensitivity and vascular function are supposed to improve14.
Cardiopulmonary exercise testing (CPX) is the preferred tool to
assess cardiorespiratory fitness and it is increasingly being used in a
wide spectrum of clinical conditions affecting exercise capacity16.
Although most studies on exercise in T2DM used CPX9,17,18, endur-
ance exercise prescription was based on a fixed fraction of _VO2max or
ofmaximal heart rate. Given that thesemethodsmay have significant
individual standard deviation, we believe that a direct estimation of
heart rate at ventilatory thresholds would detect more accurately the
optimal training intensity19.
Previous studies on the effects of exercise in T2DM were based
mostly on short-term interventions, with mean duration of 15–24
weeks9,17,18,20–22. In this study, we tested the hypothesis that a 12-
months supervised exercise training intervention on subjects with
T2DM can positively affect three major indicators: oxidative stress
markers, cardiorespiratory fitness and cardiometabolic risk.
Methods
We conducted a clinical trial involving the Sport and Exercise Medicine Centre and
the Diabetology Service, ‘‘Spedali Civili di Brescia’’ Hospital Trust, Hospital of
Montichiari, Italy.
Participants. To avoid confounding factors that could affect oxidative stress status
and cardiometabolic risk, we selected only male subjects, aged between 40 and 70
years, nonsmokers and not taking antioxidant supplements. Twenty subjects with
T2DM were recruited and randomized into an intervention group that performed
supervised exercise training for one year (SET group; n 5 10) and a control group (C
group; n 5 10) that received standard medical care only. Specific eligibility criteria
included BMI between 25 and 34.9 (overweight and grade I obesity), diagnosis of
T2DM23 for at least 2 years, metabolic syndrome phenotype24, no need for insulin
therapy, arterial hypertension and dyslipidemia controlled by statins and either ACE-
inhibitors or angiotensin receptor blockers, absence of diabetes-specific
complications and ischemic heart disease. A third group of ten healthy individuals (H
group; n 5 10) was also recruited as a reference population and it was examined only
at baseline without receiving any intervention. Eligibility criteria included BMI
between 18.5 and 24.9 (normal weight), absence of any active medical condition and
chronic medication prescription.
Research protocol was approved by the Ethics Committee of Spedali Civili di
Brescia (12 May 2010) and participants gave written informed consent. All experi-
ments were performed in accordance with the Declaration of Helsinki.
Measurements. Investigations consisted of medical examination, biochemical
analyses, systemic oxidative stress evaluation and CPX. C and SET groups were
examined at baseline (T0) and after twelve months (T12), while H group only at T0.
Medical examination was intended to rule out any contraindication to a maximal
exercise test and to assess blood pressure, waist circumference, BMI and dietary
habits. Dietary intake was studied in SET and C group with the European Prospective
Investigation into Cancer and Nutrition food frequency questionnaire25. The NAF
software (Nutritional Analysis of Food Frequency Questionnaires, National Cancer
Institute, Milan, Italy)26 was used to transform information about food composition
into total energy intake.
Biochemical analyses were performed at the laboratories of ‘‘Spedali Civili di
Brescia’’ Hospital Trust at T0 and T12. Venous blood samples were obtained from
each subject at 8:00 a.m after at least 12 hours fasting and 48 hours from the last
exercise bout; morning doses of antidiabetic medications were discontinued. The
following parameters were evaluated: fasting plasma glucose, triglycerides, total and
HDL cholesterol (Dimension Vista, Siemens Healthcare, Erlangen, Germany),
HbA1c (Variant II Biorad Bio-Rad Laboratories, Hercules, California, USA) and
serum insulin (ADVIA centaur IRI, Bayer Diagnostics Europe, Dublin, Ireland).
Insulin resistance was calculated using the Homeostasis Model of Assessment -
Insulin Resistance (HOMA-IR) formula [(serum insulin in mUI/l) 3 (fasting plasma
glucose in mMol/l)/22.5]. LDL cholesterol was estimated by the Friedewald formula.
In addition, metabolic syndrome severity score (Z-score) was calculated starting from
individual components of metabolic syndrome27.
The research laboratories of the University Hospital of Verona, Italy, evaluated
systemic oxidative stress by measuring oxidized forms of the phospholipid 1-pal-
mitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (ox-PAPC). The following
different oxPAPC were taken into consideration: 1-palmitoyl-2-(5-oxovaleroyl)-sn-
glycero-3-phosphorylcholine (POVPC); 1-palmitoyl-2-glutaroyl-sn-glycero-3-
phosphorylcholine (PGPC). Plasma and peripheral bloodmononuclear cells (PBMC)
concentrations of oxPAPC at T0 and at T12were tested. After appropriate storing and
carriage, samples were drawn into pyrogen-free blood collection tubes. Multiple
aliquots of serumwere placed into sterile 1-ml screw-capped polypropylene vials with
phenolic antioxidant 2,6- Di-tert-butyl-4-methylphenol 10 mmol/L (Sigma) added
to inhibit lipid peroxidation and stored at 280 uC. Samples were frozen and thawed
only once. PBMC were isolated as previously described28. Briefly, whole blood was
layered onto a sterile aqueous medium containing Ficoll and sodium diatrizoate at a
predetermined density of 1.007 g/ml at 25 uC. Gentle centrifugation at room tem-
perature resulted in separation of PBMC at the blood/ficoll interface, with other white
and red blood cells passing through the interface. OxPAPC in PBMC and plasma of
patients were measured on an Agilent mass spectrometer equipped with an electro-
spray source as previously described29. Flow injection experiments were performed by
an HPLC system (HP1100; Agilent Technologies). Quantification of peak areas was
performed by single ion monitoring in the elution time range of 10–20 min using
appropriate software. Authentic1-palmitoyl-2-arachidonoyl-sn-glycero-3-phospho-
choline (PAPC), POVPC and PGPC were obtained from Avanti Polar Lipids, Inc.
(Alabaster, AL).
CPX was performed on an electro-magnetically braked cycle ergometer
(Cardioline, Italy), with an incremental ramp protocol (20 W/min) until volitional
exhaustion or an evident plateau in the _VO2 versus work rate curve. Expired gases and
volumes were measured by an automated breath-by-breath respiratory gas analysis
system (Ultima CPX, Medical Graphics, USA). The Breeze Suite software (Medical
Graphics, USA) allowed to interpolate breath-by-breath gas data to 1-s values with
the preventive exclusion of outlying breaths (.63 SD from the adjacent five breaths)
and to determine gas exchange thresholds with computerized linear regression ana-
lysis (V-slope method)30. Gas exchange threshold (GET) was defined as the point
where the slope of the _VCO2 versus _VO2 curve increases31, while the ventilatory
compensation point (VCP) as the increase of the slope of the _VE versus _VCO2 curve32.
Digital 12-lead ECG was simultaneously recorded (Cardioline, Italy), sending to the
previous device information about heart rate. Blood pressure and pulse oximetry were
also monitored during the test. Outcome measures were _VO2max, _VO2 and heart rate
at GET ( _VO2GET, HRGET) and at VCP ( _VO2VCP, HRVCP).
Interventions. All subjects with T2DM received standard medical care aimed at
achieving optimal glycemic, lipid, blood pressure and body weight targets, as
established by existing guidelines23, including glucose-, lipid- and blood pressure-
lowering agents and a dietary regimen prescribed by the diabetologist. No further
nutritional intervention was given throughout the study. Medications were adjusted
throughout the study to account for potential reduced needs. Subjects in C group did
not receive any type of intervention other than standard medical care. H group did
not receive neither intervention nor follow-up.
SET group’s training program consisted of 12 months of aerobic, resistance and
flexibility training, according to the most recent guidelines10. Training sessions were
performed in a hospital-based setting and supervised by personal trainers with spe-
cialist degree in ‘‘preventive and adaptive physical activity’’. Global weekly workload
was gradually increased from 140 to 270 minutes. Endurance training involved
cycling on mechanically braked cycle ergometers while wearing heart rate monitors,
at the intensity individually prescribed according to the results of CPX. In the first two
months, endurance training was performed approximately 5 bpm below HRGET.
From the third month, training heart rates have been allowed to temporary increase
above HRGET, gradually reaching but not overcoming HRVCP, in an interval-training
fashion. Time per session has been increased progressively in the first 3 months,
starting from 15 minutes and reaching the target of 35 minutes.
Resistance training consisted of 40 to 50 minutes of different exercises involving
the major muscle groups (upper limb, lower limb, chest, back and core). Exercises
consisted both in calisthenics and repetitions with ankle weights, dumbbells and
elastic bands. Subjects began with 3 sets of 8 repetitions, then progressively improved
to 3 sets of 12–15 repetitions. For exercises requiring dumbbells, weights started from
1–3 kg and were increased up to 2–6 kg depending on the subject and the type of
exercise. Flexibility training was composed of static stretching exercises that involved
upper and lower body, before and after the resistance training sessions.
Statistical Analysis. Baseline to end-of-study changes (expressed as mean 6
standard deviation) were analyzed using Student’s t-test for paired samples. To assess
the statistical significance of differences between groups at each time point we used
Student’s t-test for independent samples. A value of p , 0.05 was considered
statistically significant.
Results
Baseline (T0). Mean age 6 standard deviation of SET, C, and H
group was respectively 60.56 6 5.94, 57.50 6 9.46 and 54.6 6 8.7
years, with no significant difference. Among subjects with T2DM, 13
(7 in SET and 6 in C) took metformin 1.5–2.5 g/day, 4 (1 in SET and
3 in C) took metformin 1.7 g/day plus pioglitazone 30 mg/day, 3 (2
in SET and 1 in C) took metformin 2 g/day plus glimepiride 3 mg/
day. As a consequence of inclusion criteria, all patients in SET and C
group took a statin and either an ACE-inhibitor or an angiotensin
receptor blocker.
www.nature.com/scientificreports
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Cardiometabolic risk, cardiorespiratory parameters and total energy
intake did not differ significantly between SET and C groups, while in H
group felt within the range of normality (Figure 1 and Table 1). Mean
_VO2max, adjusted for body weight, was nearly 21 ml?kg21?min21 for
both groups. H group had a higher maximal aerobic power in compar-
ison SET and C group ( _VO2max 27.2 ml?kg21?min21, p 5 0.03 and p 5
0.04, respectively) and a higher _VO2GET and _VO2VCP (p 5 0.006 and p
5 0.003 respectively). In all participants HRmax and maximal work rate
corresponded to more than 85% of predicted value based on an age-
and sex-matched population, concomitant exercise ECG was negative
for ischemia and there was no arterial oxygen desaturation during effort.
In SET group, mean HRGET was 116 bpm, while mean HRVCP was
129 bpm. Mean endurance exercise intensity prescription was 79% of
the measured HRmax (111 bpm, that is HRGET – 5 bpm) for the first
twomonths and between 79% and 92% ofHRmax since the thirdmonth,
when interval training was started. These values correspond to 69%–
87% of the HRmax estimated with the formula 220 – age.
oxPAPC levels are shown in Figure 2. At baseline SET/C group
presented plasma concentrations of POVPC and PGPC respectively
226%/212% and 232%/224% higher respect to H group (p 5 0.02/p
5 0.01 and p 5 0.01/p 5 0.02 respectively). No statistically signifi-
cant variation are detected in PBMC (Figure 2), but the trend is
similarly towards higher levels among SET and C groups compared
to H (p 5 0.21/p 5 0.34 and p 5 0.51/p 5 0.14).
End of the study (T12). There was no drop-out in either group. In
SET group, the two patients on metformin 2 g/day plus glimepiride
3 mg/day had the dose reduced by diabetologist to metformin 2 g/day
plus glimepiride 1 mg/day because of recurrent hypoglycemia at self-
monitored capillary glucose. 24-hour recall at T12 showed no
significant variation of total energy intake (Table 1). SET group
obtained a significant improvement in several cardiometabolic
parameters (Figure 1). Waist circumference changed from 102.1 6
10.1 cm to 100.6 6 9.6 cm (21.4%, p 5 0.01), LDL cholesterol from
102 6 30 to 81 6 24 mg/dl (220.2%, p 5 0.04), HOMA-IR from
8.22 6 5.59 to 4.22 6 3.19 (252.5%, p 5 0.02) and similarly fasting
insulinemia from 8.22 6 5.59 to 4.22 6 3.19 uUI/ml (248.5%, p 5
0.01). There was a trend towards lower body weight, BMI, HbA1c
and metabolic syndrome severity score (Table 1). Conversely, in C
group there was no significant change in any metabolic parameter
during the observation period. Compared to C group, SET group
obtained a non-significantly lower total and LDL cholesterol, fasting
insulinemia, HOMA-IR, triglycerides, systolic blood pressure, diastolic
blood pressure and metabolic syndrome severity score (Z-score).
For what concerns cardiorespiratory parameters, SET group showed
significant improvements (Figure 1). Absolute and weight-adjusted
_VO2max increased by 10.6% and 14.4%, respectively (p 5 0.04 and p
5 0.03), reaching a weight-adjusted value of 23.8 ml?kg21?min21.
Higher values of absolute and weight-adjusted _VO2GET (125.0% and
1 23.4%, p 5 0.02 and p 5 0.01 respectively) and _VO2VCP (120.3%
and 1 24.2%, p 5 0.005 and p 5 0.007, respectively) were also found,
without a significant change in the corresponding HRGET and HRRC.
Work rate at GET, work rate at VCP and maximal work rate signifi-
cantly improved, while HRmax did not vary significantly (Table 1). C
group did not show any significant change in cardiorespiratory para-
meters during the observation period, although there was a non-
significant decrease in _VO2max from 21.0 6 5.4 ml?kg21?min21 to
19.1 6 3.6 ml?kg21?min21 (29.0%). SET group achieved an absolute
and weight-adjusted _VO2max 16.6% (p 5 0.04) and 24.6% (p 5 0.01)
greater, respectively, compared to C group. SET group achieved also a
higher weight-adjusted _VO2GET and _VO2VCP (129.5% and 1 30.6%,
respectively, p 5 0.03 for both) and achieved a significantly higher
maximal work rate (Table 1 and Figure 1). At T12, weight-adjusted
_VO2max of SET group was no more significantly different from that of
H group, while that of C group still remained lower (p 5 0.0042).
For what concerns oxPAPC (Figure 2), SET group obtained a
significant decrease of plasma concentrations of POVPC and
PGPC at T12 (227.9%, p 5 0.03 and231.6%, p 5 0.04 respectively)
respect to C who obtained a decrease of 10% or lower (p 5 0.76 and p
5 0.65, respectively). A statistically significant decrease was not
achieved in PBMC, but the trend was similar to that of plasma.
Figure 1 | The most significant cardiometabolic and cardiorespiratory parameters at baseline (T0) and at the end of the study (T12). SET: supervised
exercise training. C: control. H: healthy. !: p , 0.05 vs. T0; {: p , 0.05 vs C at T12; #: p , 0.05 vs H.
www.nature.com/scientificreports
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Discussion
Our data confirms that subjects with T2DMpresent amore oxidizing
environment than healthy subjects2 and the significant decrease of
plasma oxPAPC concentrations in SET group indicates that this
specific exercise program has had a role in the amelioration of oxid-
ative stress status. It must be taken into account that the following
considerations are limited to male sex, since women were not
included. It is hereby argued that reduction of plasmatic phospholi-
pids can be due to two major mechanisms: increased antioxidant
defense and reduced ROS production. Increased antioxidant defense
may involve an exercise-induced stimulation of the antioxidant res-
ponse pathway. For this purpose it would be of interest to study the
transcription factor NF-E2-related factor 2 (Nrf2), which is respons-
ible for the expression of antioxidant response genes. It has been
demonstrated that in T2DM there is a deregulated Nrf2-dependent
antioxidant defense pathway with increased inflammatory status and
it has been shown that antioxidant activity is enhanced by exercise
and increases in response to endurance training12,13. Decreased ROS
production may involve a reduced substrate overload in mitochon-
dria, either thanks to a decreased blood glucose and LDL concentra-
tions or a training-induced improved mitochondrial function. A
limitation of this study is the paucity of different ROS-modified
biomolecules investigated. Lipid peroxidation could have been more
deeply evaluated with detection of additional lipid hydroperoxides3,
whereas oxidative modification of proteins could have been investi-
gated with dosage of protein carbonyls and nytrotirosin33. Actually,
all these markers could be sensitive to a lifestyle intervention33,34. The
absence of statistically significant changes in PBMC could be due to
the low numerousness of the sample, to a possible low intensity of the
training program (as discussed below) and to the lack of a clinically
meaningful weight loss. Furthermore, the absence of diabetes-
specific complications and the good blood glucose control (mean
HbA1c values were ,7.0%) are favorable factors that could protect
circulating cells without allowing accumulation of oxidative products.
Since evidence for oxidative stress as a key mechanism altering
insulin resistance has been widely discussed2,4, the significant reduc-
tion HOMA-IR in SET group confirms this pathogenetic event and
suggests that it can be partially reversed. From a molecular point of
view, there is evidence that ROS contribute to insulin resistance and
to the activation of pro-inflammatory signaling pathways, mainly
regulated by the transcription factor kB (NF-kB)35. Conversely, insu-
lin has a strong anti-inflammatory effect, including a reduction in
intranuclear NF-kB and decrease of ROS generation36, so it is
also possible that the improvement of HOMA-IR was at least par-
tially sustained by the reduction of systemic oxidative stress.
Unfortunately, HOMA-IR is not the gold standard for the quan-
tification of insulin resistance, so caution is needed in interpreting
these results. Another limitation is not having taken into account
post-prandial changes in oxidative stress markers, which would have
provided more understanding of exercise-diet interactions. Since
glucose fluctuations exhibited a more specific triggering effect on
oxidative stress than chronic sustained hyperglycemia37, it could be
stimulating to evaluate also intraday glycemic variability with con-
tinuous glucose monitoring systems.
Previous studies and meta-analyses showed that structured
exercise training improves physical fitness in subjects with T2DM,
along with a reduction of HbA1c9,21. In our study we found a non-
significant reduction of HbA1c (p 5 0.08), despite a significant
improvement of HOMA-IR. This is probably due to the low number
of subjects enrolled in SET group (n5 10), themean baseline HbA1c
value,7.0% (which suggests optimal diabetes control), the decrease
of ant-diabetic medications in two subjects and the absence of a
specific nutritional intervention.
Despite a slight decrease of bodyweight was observed in all groups,
this difference is not statistically significant, while a significant reduc-
tion in waist circumference has been observed (21.5 cm). This is
consistent with other studies, where an increase in fat free mass and a
decrease in fat mass is reported without changes in total body
weight38. Supervised exercise training produced a significant reduc-
tion of LDL cholesterol in subjects already on statins, not observed in
previous trials on T2DM8. However, the significant reduction in
body fat39 or even the training alone40 could be responsible for this
finding. Variations in adherence to statin therapy is also to be taken
in consideration.
Figure 2 | 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine (POVPC) and 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcholine
(PGPC) levels in plasma and in peripheral bloodmononuclear cells (PBMC) at baseline (T0) and at the end of the study (T12). SET: supervised exercise
training. C: control. H: healthy. !: p , 0.05 vs. T0; #: p , 0.05 vs H.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 9238 | DOI: 10.1038/srep09238 5
Our findings strengthen the theory that subjects with T2DM and
overweight have decreased exercise capacity compared to healthy
subjects7. In fact, at baseline both SET and C group presented a
low _VO2max. The hypothesis to explain this finding are various in
literature: advanced age, increased BMI, poor diabetes control, left
ventricle diastolic dysfunction and diabetic neuropathy7. In our sub-
jects, we hypothesize that the low exercise capacity is mainly due to a
very important cardiovascular and muscular deconditioning and to
an increased body mass, both likely caused by several years of sed-
entary lifestyle. In fact, _VO2max substantially improved after one year
of reconditioning (23.8 ml?kg21?min21). We want to emphasize that
_VO2max, in addition to his physiological importance, represents a
prognostic index that is inversely related to cardiovascular and all-
cause mortality41 and should not be overlooked when estimating
cardiometabolic risk.
It is to be remarked that all subjects with T2DM were on metfor-
min, a drug that has been found to blunt several effects of exercise,
like improved cardiorespiratory fitness42 and in insulin sensitivity43,
although there are conflicting findings44. In our study, we cannot
exclude these detrimental effects, given the limited cardiometabolic
responses despite the long duration of the training program. It has
also been demonstrated that, by increasing heart rate, metformin
could lead to the prescription of a lower endurance exercise intens-
ity45.We believe that this is not occurred in our study, since the direct
assessment HRGET and HRVCP with CPX permits to bypass this
effect, in analogy to what happens with beta blockers. A theoretical
risk of sub-optimal endurance intensity prescription is in any case
present in the later phases of the intervention, since our study lacks of
an intermediate CPX to better adapt the progression of training to
individual physiological adaptations.
Along with cardiorespiratory fitness, increased strength plays an
important role in intramuscular glucose and fat uptake and oxida-
tion, contributing along with cardiorespiratory fitness to an
increased insulin sensitivity and a decreased visceral fat in subjects
with T2DM10. In our study, resistance exercise prescription was less
standardized than endurance, with a drift towards lighter weights,
maybe explaining some blunted cardiometabolic and antioxidant
adaptations to training.
The long-term compliance of SET group subjects deserves a spe-
cial mention, as no one dropped out from the study. This might be
possible thanks to a personalized approach, a protected training
environment, the supervision of qualified exercise professionals
and the gratuitousness of the service offered. In contrast, physical
activity advice alone or theory-based intervention gathered only poor
results22,46.
In conclusion, this study demonstrates that personalized and
supervised exercise training of 1-year duration can affect positively
insulin sensitivity and blood levels of LDL cholesterol. Increased
cardiorespiratory fitness and a healthier body composition are prob-
ably the underlining causes. All these factors, with complex interac-
tions, might have brought to a reduced systemic oxidative stress, as
revealed by plasmatic oxPAPC. Moreover, the reduction of systemic
oxidative stress may have had a positive feedback on insulin sens-
itivity. This provides new insights into the molecular mechanisms of
non-pharmacologic treatment of chronic diseases.
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